M1 Kliniken Past Earnings Performance
Past criteria checks 5/6
M1 Kliniken has been growing earnings at an average annual rate of 7.2%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 25.6% per year. M1 Kliniken's return on equity is 13.3%, and it has net margins of 5%.
Key information
7.2%
Earnings growth rate
6.0%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 25.6% |
Return on equity | 13.3% |
Net Margin | 5.0% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?
Oct 15Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%
Sep 24Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28Revenue & Expenses Breakdown
How M1 Kliniken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 333 | 17 | 2 | 0 |
31 Mar 24 | 325 | 14 | 2 | 0 |
31 Dec 23 | 316 | 10 | 2 | 0 |
30 Sep 23 | 307 | 8 | 2 | 0 |
30 Jun 23 | 297 | 6 | 2 | 0 |
31 Mar 23 | 291 | 5 | 2 | 0 |
31 Dec 22 | 285 | 4 | 2 | 0 |
30 Sep 22 | 287 | 6 | 2 | 0 |
30 Jun 22 | 288 | 7 | 2 | 0 |
31 Mar 22 | 302 | 8 | 2 | 0 |
31 Dec 21 | 315 | 9 | 2 | 0 |
30 Sep 21 | 304 | 9 | 2 | 0 |
30 Jun 21 | 293 | 10 | 2 | 0 |
31 Mar 21 | 226 | 8 | 2 | 0 |
31 Dec 20 | 160 | 7 | 2 | 0 |
30 Sep 20 | 118 | 7 | 2 | 0 |
30 Jun 20 | 76 | 6 | 1 | 0 |
31 Mar 20 | 77 | 8 | 1 | 0 |
31 Dec 19 | 77 | 10 | 1 | 0 |
30 Sep 19 | 73 | 8 | 2 | 0 |
30 Jun 19 | 69 | 7 | 2 | 0 |
31 Mar 19 | 67 | 7 | 2 | 0 |
31 Dec 18 | 65 | 7 | 2 | 0 |
30 Sep 18 | 60 | 6 | 2 | 0 |
30 Jun 18 | 54 | 5 | 2 | 0 |
31 Mar 18 | 51 | 6 | 2 | 0 |
31 Dec 17 | 47 | 6 | 2 | 0 |
30 Sep 17 | 43 | 6 | 1 | 0 |
30 Jun 17 | 40 | 6 | 0 | 0 |
31 Mar 17 | 38 | 5 | 0 | 0 |
31 Dec 16 | 36 | 5 | 0 | 0 |
30 Sep 16 | 40 | 7 | 0 | 0 |
30 Jun 16 | 43 | 10 | 0 | 0 |
31 Mar 16 | 39 | 8 | 0 | 0 |
31 Dec 15 | 35 | 7 | 0 | 0 |
31 Dec 14 | 23 | 5 | 0 | 0 |
31 Dec 13 | 6 | 0 | 0 | 0 |
Quality Earnings: M12 has high quality earnings.
Growing Profit Margin: M12's current net profit margins (5%) are higher than last year (2.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M12's earnings have grown by 7.2% per year over the past 5 years.
Accelerating Growth: M12's earnings growth over the past year (163.7%) exceeds its 5-year average (7.2% per year).
Earnings vs Industry: M12 earnings growth over the past year (163.7%) exceeded the Healthcare industry 40.5%.
Return on Equity
High ROE: M12's Return on Equity (13.3%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 08:33 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
M1 Kliniken AG is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Charlotte Friedrichs | Berenberg |
Stephan Klepp | Commerzbank AG |
Edward Acklin | First Berlin Equity Research GmbH |